Defymed Inc.
Implantable, bioartificial devices for a range of therapeutic applications
This article was originally published in Start Up
Executive Summary
Defymed Inc.’s MAILPAN (MAcro-encapsulation of PANcreatic Islets) is a bioartificial pancreas that can use a broader pool of cell types while protecting the cells from rejection by the immune system.